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Abstract
Background: Prolonged disorders of consciousness (PDOC) may occur after severe brain injury. Two diagnostic
entities are distinguished within PDOC: unresponsive wakefulness syndrome (UWS, previously known as vegetative
state) and minimally conscious state (MCS). Patients with PDOC may benefit from early intensive neurorehabilitation
(EIN). In the Netherlands, the EIN programme is provided by one designated expert rehabilitation centre and forms
the starting point of a dedicated chain of specialised rehabilitation and care for this group. This study project, called
DOCTOR: Disorders of Consciousness; Treatment and Outcomes Registry, sets up a registry and systematically
investigates multiple short- and long-term outcomes of patients with PDOC who receive EIN.
Methods: Single-centre prospective cohort study with a 2-year follow-up period. Patients with PDOC due to acute
brain injury who receive EIN, aged 16 years and older are included. Measurements will take place at start EIN, in
week 5, 10, and at discharge from the EIN programme (duration =max 14 weeks) and at week 28, 40, 52, and 104
after admission to the EIN programme, following patients through the health-care chain. Outcome measures are
the changes over time in level of consciousness, using the Coma Recovery Scale-Revised; the frequency and type of
medical complications; the mortality rate; level of disability, including the level of motor, cognitive, behavioural and
emotional functioning; participation; and quality of life. Secondary outcomes include self-efficacy of caregivers,
caregivers’ strain and cost-effectiveness of the programme.
Discussion: The DOCTOR study will provide insight in the recovery patterns and predictors of recovery for multiple
outcomes in PDOC patients after following EIN. The results of the study will enable us to benchmark and improve
EIN and the organisation of the health-care chain, both for patients with PDOC and for their families.
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Background
Prolonged disorders of consciousness (PDOC) (> 4
weeks) due to acquired brain injury (ABI) although un-
common [1, 2] have a major impact on patients and
their families [3]. Two diagnostic entities are distin-
guished within PDOC: the unresponsive wakefulness
syndrome (UWS, previously known as vegetative state)
and the minimally conscious state (MCS) [4, 5]. In
UWS, persons display spontaneous eye opening and
sleep/wake cycles, but observable signs of purposeful be-
haviour (e.g. language comprehension, behavioural re-
sponse to stimuli) are absent [6]. Patients in MCS
demonstrate minimal but definitive behavioural evidence
of awareness. Conscious behaviour in MCS is often sub-
tle and inconsistent, and must be systematically differen-
tiated from reflexive or random behaviour [6]. Based on
the complexity of behaviour, a differentiation is made
between MCS-minus (MCS-) and MCS-plus (MCS+) [7,
8]. MCS+ is distinguished from MCS- by the evidence of
language processing [7]. PDOC can arise from various
aetiologies, but the most common causes in adults are
traumatic brain injury, intracerebral and subarachnoid
haemorrhage and hypoxic-ischemic encephalopathy [4,
9, 10]. Hypoxic-ischemic encephalopathy is the most
common cause in UWS patients (38–50%) [9, 11], while
cerebral haemorrhage is most common in MCS [9]. Van
Erp et al. reported a prevalence of 0.1 to 0.2 hospitalised
and institutionalised UWS patients per 100,000 mem-
bers of the general Dutch population [11] while world-
wide prevalence varies from 0.2 up to 6.1 per 100,000
[1]. PDOC patients may benefit from subacute neuror-
ehabilitation, such as early intensive neurorehabilitation
(EIN). EIN focuses on (1) basic care and prevention of
complications [12] (e.g. thrombo-embolic disease, con-
tractures, skin breakdown, paroxysmal sympathetic
hyperactivity), which cause a substantial raise in morbid-
ity, discomfort and pain, and in healthcare costs [13]; (2)
accurate assessment and treatment aimed to facilitate re-
covery of level of consciousness (LOC); (3) finally, pro-
viding comprehensive education and empowerment of
families to foster families’ coping.
Research on recovery shows that 38 and 78% of pa-
tients with PDOC due to traumatic brain injury (TBI)
regain (minimal) consciousness at respectively 3 and 12
months post injury [2]. In patients with non-traumatic
brain injury (NTBI) only 17% regains consciousness at 8
months post injury [2]. Aidinoff et al. [14] demonstrated
an improvement in survival and recovery of
consciousness in UWS patients over the last two decades
after EIN, and similar outcomes for both TBI and NTBI
UWS. These outcomes suggest that improvements in
acute medical care and EIN have contributed to ad-
vances in UWS care. Treatment started within 8 weeks
after injury is associated with better outcomes in terms
of LOC and functioning, gained in a faster pace than
treatment started after 8 weeks [15–17]. In patients with
PDOC of mixed aetiology with a mean time follow-up of
5 years, 40% of survivors reached functional independ-
ence, while 42% of patients able to respond to a self-
report questionnaire, reported a poor quality of life [18].
The EIN programme in the Netherlands has been stud-
ied before; in patients aged < 25 years recovery of con-
sciousness occurred in two-thirds at the end of the EIN
programme [19] and two-thirds of the patients who were
fully conscious at discharge were able to live independ-
ently after 10–12 years [20].
Prognostic factors associated with better recovery from
PDOC are younger age at onset, traumatic aetiology, less
severe comorbidities and less severe neurological impair-
ment, i.e. higher level of consciousness at admission to
EIN [2, 4, 15, 21–25]. However, most studies on recov-
ery after PDOC suffer from methodological issues, such
as a retrospective design [2] and variability in clinical de-
cision making in acute care [2]. Further, research on
outcomes after PDOC often fails to discriminate be-
tween diagnostic subtypes (UWS or MCS), aetiology and
the time since injury [2]. Furthermore, data on quality of
life, costs and cost-effectiveness of rehabilitation pro-
grammes, and caregiver burden are limited.
The Disorders of Consciousness Treatment and Out-
comes Registry (DOCTOR) is a prospective follow-up
study on outcomes for all patients ≥16 years in UWS
and MCS and their families who entered the EIN
programme in one designated expert rehabilitation
centre in the Netherlands. It is a 14-week subacute in-
tensive neurorehabilitation programme for patients dis-
charged from the intensive care unit or hospital ward, to
improve (recovery of) consciousness, prevent complica-
tions and empower caregivers.
In DOCTOR outcomes of patients with PDOC are re-
corded systematically with a follow-up of 24 months
after admission to EIN. Main outcome measures are
(predictors) of recovery of LOC, mortality, incidence and
type of complications, outcomes in terms of level of
disability, including the level of motor, cognitive, behav-
ioural and emotional functioning, pain, cognition,
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participation and quality of life. Further, caregiver
burden and self-efficacy will be assessed as well as cost-
effectiveness.
Methods
Study design and setting
The DOCTOR study is a nationwide single-centre
prospective cohort study with 2 years follow-up. Mea-
surements take place at start EIN, in week 5, 10, and at
discharge of the EIN programme (duration =max 14
weeks) and at week 28, 40, 52, and 104 after admission
to the EIN programme, following patients through the
health-care chain. (Fig. 1).
The EIN programme is standard care and is provided
in a single specialised rehabilitation centre in the
Netherlands. All hospitals in the Netherlands may refer
patients who are eligible for EIN to this centre. Informed
consent is obtained from the legal representative of each
patient before the start of the study. Patients who show
sufficient recovery of consciousness during the study
trajectory will personally be asked consent for further
participation in the study.
This study is not subject to the “Medical Research
Involving Human Subjects Act”, determined by the
Medical Ethics Committee of Erasmus MC, University
Medical Centre Rotterdam (MEC-2019-0127).
In- and exclusion criteria
Patients with PDOC due to acute brain injury who are
admitted to the EIN programme are possible candidates
for this study. At admission to EIN, patients will be
screened for eligibility for DOCTOR. Patients are in-
cluded in DOCTOR if the in- and exclusion criteria are
met (Table 1).
EIN programme
The EIN programme is a subacute medical rehabilitation
programme of 14 weeks (or less when recovery of
Fig. 1 Study design
Driessen et al. BMC Neurology           (2021) 21:69 Page 3 of 10
consciousness occurs earlier) and meets the guideline
recommendations for patients with PDOC published by
the American Academy of Neurology [26]. An interdis-
ciplinary rehabilitation team of a rehabilitation physician,
a physician assistant, a neuropsychologist, cognitive re-
habilitation therapists, physiotherapists, occupational
therapists, speech therapists, nursing staff, dietician, and
social worker uses an integrated approach in a 24/7 set-
ting [19] with a minimum duration of 120 min therapy
per day in which daily routines are built in together with
a structured scheme of therapy and rest. The program is
focused on optimizing the metabolic state, nourishment,
respiration and skin condition, as well as diminishing
the risk of infections and quick removal of invasive de-
vices, like a tracheostomy tube or a urinary catheter, and
recovery of the normal circadian cycle. Pharmacological
treatments and structured stimulation of all sensory mo-
dalities (vision, hearing, smell, taste, touch, posture and
motion, pain and temperature) aim to generate maximal
arousal. As soon as the patient shows any voluntary re-
actions, reflecting a change from UWS into MCS, the
focus of treatment changes from stimulation to training
of cognitive functions. Motor rehabilitation aimed at
optimising postural and motor activity helps restore
bodily integrity and reduces the risk of complications
(e.g., infection, thrombo-embolic complications, skin
breakdown). For patients who reach MCS, increased
time is spent on training mobility and self-care. Coping
and self-efficacy of caregivers are addressed with psy-
choeducation, counselling and hands-on training in
handling the patient.
After EIN, patients are discharged to 1) a regular
neurorehabilitation setting in case of full recovery of
consciousness and the ability to participate in a rehabili-
tation programme as judged by the rehabilitation phys-
ician, 2) to skilled nursing facilities, 3) sheltered housing
or 4) possibly home (Fig. 2). Some skilled nursing facil-
ities offer a prolonged intensive neurorehabilitation
programme (PIN) for further recovery of consciousness
during a period of up to 24 months post-injury. EIN is
part of an academic network of expertise (EENnaComa)
in which various healthcare institutes specialised in post-
Table 1 Inclusion and exclusion criteria
Inclusion criteria
Age16 years or older
PDOC (UWS or MCS) lasting > 4 weeks and < 6 months at admission
to EIN
First-time newly acquired non-progressive brain injury of any
aetiology
Weaned from ventilator
Medically stable, as judged by the treating rehabilitation physician
Exclusion criteria
Coma
Any pre-existent progressive or non-progressive brain injury
Uncontrollable epilepsy
Fig. 2 Healthcare pathways for PDOC. EIN: Early intensive neurorehabilitation –duration max 14 weeks. PIN: Prolonged intensive
neurorehabilitation –up to 2 years post injury
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acute and long-term care of PDOC patients and their
families are united.
Data collection
In 4 years we aim to include 72 patients. Structured data
collection (Fig. 3) will take place at the start of the EIN
programme at week 5, 10, and at EIN discharge (week
14). LOC assessment and registration of complications
will be done weekly.
After discharge from EIN, follow-up measurements
are planned at 28, 40, 52, and 104 weeks post-inclusion.
These will take place at the patients’ actual health-care
institution or residence.
All measurements conducted during the EIN
programme are performed by trained members of the
rehabilitation team. Follow-up measurements are per-
formed by a trained research assistant.
Complications
The number and type of complications is classified ac-
cording to the International Classification of Function-
ing, Disability and Health (ICF) in the domain of
functions and structures (Table 2). In addition, the num-
ber of imaging studies and types of treatments for com-
plications (surgery, non-surgery, ICU transfers,
procedures i.e.) are recorded.
Mortality
We will register the following causes of death: [28].
Fig. 3 Measurement plan
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 Death from (co) morbidity despite treatment
 Death from comorbidity after a non-treatment deci-
sion (non-resuscitation or withholding treatment for
medical complications)
 Death after withdrawal of artificial nutrition and
hydration.
Measurement instruments
Coma recovery scale revised (CRS-R)
The CRS-R [29] is a bedside assessment tool for differ-
entiating levels of consciousness by observation of
responses to various stimuli. It is composed of 6 hier-
archical subscales: auditory, visual, motor, oromotor/ver-
bal, communication and arousal with 23 dichotomously
scored items [30]. The item content of the CRS-R identi-
fies ascending levels of conscious behaviour/ability and
using a combination of items to differentiate UWS from
MCS from emerged from an MCS based on The Multi-
Society Task Force on Persistent Vegetative State and
Aspen Workgroup criteria [29]. An American Congress
of Rehabilitation Medicine practice parameter recom-
mends the use of the CRS-R based on its standardised
administration and scoring procedures, item content,
and inter-rater and test-retest reliability [26, 29].
Nociception coma scale (NCS)
The NCS is a nociception behaviour observation tool,
developed for patients with PDOC [31]. It includes four
subscales assessing motor, verbal, visual and facial re-
sponses; each subscore ranges from 0 to 3 (total score:
0–12). A higher total score indicates a higher level of
possible discomfort and pain [32].
Disability rating scale (DRS)
The DRS is an observational measurement of the levels
of arousal, awareness, and responsiveness (including eye
opening, communication ability, and motor response);
cognitive ability of self-care activities (such as feeding,
using the toilet, and grooming); dependency on others
(level of functionality); and psychosocial adaptability
(employability). The DRS score ranges from 0 to 29 (low
to high level disability) and scores are categorised into
the following disability categories: 0 = none, 1 =mild, 2–
3 = partial, 4–6 =moderate, 7–11 =moderately severe,
12–16 = severe, 17–21 = extremely severe, 22–24 = vege-
tative state, and 25–29 = extreme vegetative state. The
DRS has been used as an outcome measure in multiple
previous studies on PDOC outcome [13, 15, 17, 19].
Functional Independence measure (FIM)
The FIM measures the level of a patient’s disability and
indicates how much assistance is required for conduct-
ing activities of daily living [33]. The FIM contains 18
items composed of 13 motor tasks and 5 cognitive tasks.
Tasks are rated on a 7-point scale, ranging from 1 = total
assistance to 7 = complete independence. FIM total
scores range from 18 to 126, with higher scores reflect-
ing a higher level of functioning [34].
Community integration questionnaire (CIQ)
The CIQ is a 15-item questionnaire that assesses partici-
pation in 3 domains: within the home environment, in
social interactions, and in productive activities (work,
school, or volunteering) [35]. The basis for scoring is
primarily the frequency of performing activities or roles,
with secondary weight given to whether activities are
done jointly with others, and the nature of these other
persons (for example, with/without TBI). CIQ scores
range from 0 to 29, a higher total score indicates a
higher level of participation.




o Paroxysmal Sympathetic Hyperactivity (PSH)
o Disturbed sleep/wake cycles
• Sensory systems
• Cardiovascular, haematologic, immunologic and respiratory systems
o Thromboembolic disease
o Abnormal laboratory findings (e.g. hyponatremia)
• Digestive, metabolic and endocrine systems
o Gastro-intestinal: vomiting, diarrhoea, obstipation
• Genitourinary and reproductive systems
• Musculoskeletal and movement-related systems
o Contractures measured by joint range of motion (ROM)
o Spasticity: Modified Ashworth scale
o Heterotopic ossification
• Skin and related structures
o Skin breakdown: EPUAP stages I-IV (Dutch guideline: pressure ulcer:
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EuroQuol-5D-5L (EQ-5D-5L)
Health-related quality of life is measured using the EQ-
5D-5L [36, 37]. It consists of a 5-item EQ-5D index (mo-
bility, self-care, usual activities, pain/dis- comfort and
anxiety/depression) and a visual analogue scale (EQ-
VAS). Psychometric properties of the Dutch version are
shown to be good. The five EQ-5D index items are sum-
marised into one weighted overall score, which runs
from 0 for the value of death to 1.00 for full health. The
EQ-VAS ranges from 0 to 100 (worst to best imaginable
health state). For the general Dutch population average
EQ-5D index = 0.843 and average EQ-VAS = 81.36 [37].
At the start of the study, the questionnaire will be com-
pleted only by proxy, as soon as the patient regains con-
sciousness, the questionnaire will be filled in both by
proxy and patient.
Quality of life in brain injury (QOLIBRI)
The QOLIBRI was developed by an international task
force in two multi-language studies involving more than
2000 persons after traumatic brain injury (TBI) [38].
The QOLIBRI is a comprehensive questionnaire with 37
items covering six dimensions of disease-specific health-
related quality of life (HRQoL). The questionnaire pro-
vides a profile of quality of life together with a total
score. The QOLIBRI scores are reported on a 0–100
scale, where 0 is the worst possible quality of life and
100 the best possible quality of life.
Hospital anxiety and depression scale (HADS)
The Dutch Hospital Anxiety and Depression Scale is
used as a general measure of emotional distress and
contains two subscales: anxiety and depression [39].
Subscale scores ≥8 might indicate the presence of a
depressive disorder or an anxiety disorder. Reliability
and validity are adequate for several clinical popula-
tions, including multiple sclerosis and acquired brain
injury [40, 41].
The Montreal cognitive assessment (MoCA)
The MoCA is designed as a rapid screening instrument
for cognitive dysfunction [42]. It assesses different cogni-
tive domains: attention and concentration, executive
functions, memory, language, visioconstructional skills,
conceptual thinking, calculations, and orientation. The
total possible score is 30 points; a score of ≥26 is consid-
ered as normal, 18–25 indicates mild cognitive impair-
ment, 10–17 moderate cognitive impairment and < 10
severe cognitive impairment.
Neuropsychiatric inventory (NPI)
The Neuropsychiatric Inventory (NPI) is designed to be
a retrospective (last month) interview assessing neuro-
psychiatric symptoms conducted with informants about
patients for whom they care. The NPI consists of 12 do-
mains, with each domain reflecting a cardinal neuro-
psychiatric symptom. The NPI provides symptom
frequency, severity and distress ratings for each symp-
tom reported, and total severity and frequency scores
reflecting the sum of individual domain scores (range 0–
144). A higher total score indicates a higher number of
neuropsychiatric symptoms [43, 44].
Self-efficacy of caregiver (GSES)
Partners’ general self-efficacy is measured using the
General Self-efficacy scale (GSES) [45]. This self-
assessment scale contains 10 items scored on a 4-point
scale ranging from ‘completely incorrect’ to ‘completely
correct’. By adding all item scores, a total score is ob-
tained with higher scores indicating greater self-efficacy.
Caregiver strain index (CSI)
The CSI assesses informal caregiver’s burden. The CSI
contains 13 items. Scores range from 0 to 13, with
higher scores indicating higher burden [46].
Trimbos and iMTA questionnaire on costs associated with
psychiatric illness (TiC-P)
The TiC-P will be used to collect data on healthcare use
from both a healthcare and societal perspective during
follow-up. This questionnaire consists of two parts. The
first part consists of questions on the number of consul-
tations with healthcare providers during the previous 2
months. These include outpatient visits, hospital admis-
sions, day care, etc. Also, the frequency and dosage of
medication use is recorded. The second part of the TiC-
P includes the Short Form of the Health and Labour
Questionnaire (SF-HLQ), which involves questions on
absence from and return to paid or voluntary employ-
ment for measuring productivity losses [47].
Statistical analysis
Descriptive statistics will be used to present the out-
comes of the study parameters and the socio-
demographic data. Means and standard deviations will
be calculated for variables on an interval scale and
medians and interquartile ranges for ordinal variables.
Proportions will be calculated for nominal variables.
Subgroup analyses will be performed for patients pre-
senting in UWS versus MCS at baseline and for trau-
matic versus non-traumatic disorders of consciousness.
The proportions of patients transitioning from UWS
to MCS and emergence from MCS to the conscious
state will be calculated during and after EIN.
The course of recovery of consciousness (yes/no) over
time will be analysed using Generalized Estimating
Equations (GEE) analysis for logistic outcomes on an
intention-to-treat basis. Assuming that data are missing
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at random, data imputation is unnecessary in GEE ana-
lysis; all observations are taken into account in contrast
to complete case analyses. Recovery (yes/no) at each
time point will be included as the dependent variable in
the GEE model. Separate models will be generated for
transitions from UWS to MCS and from MCS to the
fully conscious state based on the CRS-R. Independent
variables that will be added one by one to the models,
include- measurement time (weeks), traumatic vs. non-
traumatic aetiology, age at injury, and complications
(yes/no or number). Significant predictors (p < 0.05) will
be included in a multivariable model using a Bonferonni
correction, dividing the significance level (alpha< 0.05)
by the number of predictors included in the model.
Also using GEE analysis, the course of quality of life
(EQ-5D-5L and Qolibri) and participation (CIQ) over
time will be analysed using separate linear outcome
models. The effects of time, cognitive (MoCa), behav-
ioural (NPI), emotional (HADS), and motor status
(FIM), and level of disability (DRS) and discomfort
(NCS) on quality of life or participation during follow-
up will be studied by adding these time-dependent
variables (one by one) as independent variables to the
models. Significant predictors (p < 0.05) will be added
into a multivariable GEE-model to study the independ-
ence of these potential predictors on the outcomes using
the Bonferroni correction.
In caregivers, self-efficacy (GSES) and caregiver strain
(CSI) are measured, which will also be modelled using
GEE analyses. Independent variables added to these
models include age and gender of the caregiver and the
level of consciousness (UWS, MCS, or conscious), and the
cognitive (MoCA) and motor (FIM) status of the patients.
Discussion
In this manuscript we present the DOCTOR study on
outcomes of EIN in patients with PDOC due to acute
brain injury. EIN is open to the entire adult Dutch
PDOC population centralised in a single specialised
centre. This study complies with recent guidelines on
PDOC of The Royal College of Physicians (2020), which
advocates the establishment of a national registry and
agreed on a minimum dataset for the collection of
national cohort of longitudinal outcome data for all pa-
tients in PDOC [48].
Besides clinical characteristics, functional outcomes
and employment, caregiver’s burden and the quality of
life in both patient and their family will be assessed. The
results of the study will provide insight in the recovery
patterns and the predictors of recovery of PDOC in the
Netherlands, which will enable us to benchmark and im-
prove EIN and to improve the prediction of outcome.
Embedded in the DOCTOR study is the TOPDOC
study. The TOPDOC study is a qualitative study that
focuses on clinical decision-making regarding treatment
and end-of-life care, ethical dilemmas, quality of out-
comes, dying and quality of dying in PDOC, involving
patients, families and healthcare professionals. The
DOCTOR and TOPDOC studies provide a rich and
solid dataset that will grasp the complexity of PDOC in
terms of functional and meaningful recovery and gives a
unique opportunity to improve and strengthen inte-
grated care pathways for PDOC care in the Netherlands.
There are some limitations in this study that need to
be discussed. First, as EIN is standard care a randomized
controlled trial design is not feasible for ethical reasons.
Second, LOC determination in PDOC is difficult in the
absence of a gold standard. Recent guidelines advocate
the use of additional diagnostic techniques such as EEG
beside a behavioural assessment in the diagnostic
process [26, 49]. However, to date these are not imple-
mented in daily PDOC care in the Netherlands. In
DOCTOR, we use the CRS-R, the most frequently used
instrument worldwide [26]. While assessing LOC by
using CRS-R, confounding factors such as motor, visual,
auditory and/or cognitive impairments (e.g., language,
memory, flexibility, attention) [50], intubation, sedation
and the setting (e.g., presence or absence of relatives)
should be taken into consideration [51], as they may
negatively influence the diagnostic evaluation. Third, the
follow-up time of our study is limited to 2 years. While
some patients may show later recovery, the most signifi-
cant proportion of recovery of consciousness after brain
injury takes place in the first 1 to 1.5 years [48]. How-
ever, due to the high rate of misdiagnosis in PDOC, the
evidence on ‘late’ recovery from PDOC may suffer from
a diagnostic delay bias [52]. While most functional re-
covery occurs by 1-year post-injury, improvements may
occur over a more prolonged interval. Some studies have
shown significant improvement in cognitive and motor
function in TBI patients admitted to inpatient rehabilita-
tion from rehabilitation discharge to year 1, year 1 to 2,
year 2 to 5 and year 5 to 10. However, the gains noted
across functional areas by 2, 5 and 10 years after injury
were relatively small compared with the first year post-
injury [17, 53, 54]. Therefore, we think that a follow-up
of 2 years will provide a good representation of the re-
covery after DOC in the long term, both for regaining
consciousness and level of cognitive, behavioural, emo-
tional and motor functioning.
To summarize, in this contribution we present the
protocol of the DOCTOR study: a nationwide single-
centre prospective cohort study of the outcomes of
PDOC patients enrolled in Early Intensive Neuroreh-
abilitation, followed up to 2 years after admission,
which will provide insight in the long-term recovery
patterns and predictors of multiple outcomes in pa-
tients with PDOC.
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